A patent review of histone deacetylase 6 inhibitors in neurodegenerative diseases (2014-2019)
{{output}}
Introduction: Histone deacetylase 6 (HDAC6) is unique in comparison with other zinc-dependent HDAC family members. An increasing amount of evidence from clinical and preclinical research demonstrates the potential of HDAC6 inhibition as an effective therapeuti... ...
